Interestingly, Tian et al. [21] predicted that miR-363-5p and miR-765 could be potential molecules to target LHPP expression in AFP-negative HCC patients, providing researchers a new perspective to investigate LHPP mechanisms in tumorigenesis. This evidence concerns the gene LHPP and hepatocellular carcinoma.